On February 3rd, 2022, TAG, in collaboration with the International Network of People who Use Drugs (INPUD), Harm Reduction International (HRI), and the World Hepatitis Alliance (WHA), hosted a free webinar, “Promoting Interventions for Viral Hepatitis and Harm Reduction in COP 2022.” The webinar focused on how to integrate viral hepatitis programming and harm reduction into COP guidance, to more effectively engage people who inject drugs.
The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) is the largest source of funding for the HIV response globally. It is critical that these funds meet the needs of all people living with and affected by HIV and viral hepatitis, particularly people who inject drugs, who are disproportionately affected and excluded from care. PEPFAR Watch brings together activists ahead of the Country Operational Plan (COP) planning process to develop priority recommendations and community demands for PEPFAR.
Hilary McQuie, Treatment Action Group
• Prioritizing Hepatitis C Virus (HCV) in PEPFAR COP 2022 – Joelle Dountio Ofimboudem, Treatment Action Group
• Hepatitis B Integration for PEPFAR — Danjuma Adda, World Hepatitis Alliance
• Drug Use in African PEPFAR-Recipient Countries: What Do We Know? — Maria-Goretti Loglo, International Drug Policy Consortium
• Where Does PEPFAR Stand on People Who Use Drugs: Recommendations For and By People Who Use Drugs – Aditia Taslim, International Network of People who Use Drugs
• Failure to Fund – Colleen Daniels, Harm Reduction International
Video recordings of the full webinar in English and Portuguese are below.